Search - tctmd.com

Displaying 61 - 80 of 342

Sort: Relevancy | Date

Presentation TCT 2021

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

Presenter: Marco Valgimigli

November 05, 2021

Presentation TCT 2021

DAPT Duration in High Bleeding Risk Patients: Lessons From Registries

Presenter: Davide Cao

November 05, 2021

Presentation TCT 2021

Debate: Follow the Bleeding Risk, Shorten DAPT!

Presenter: Dominick Angiolillo

November 05, 2021

Presentation TCT 2021

Debate: Follow the Ischemic Risk, Prolong DAPT!

Presenter: Robert Yeh

November 05, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

Presentation TCT 2021

When to Shorten DAPT: Key Messages

Presenter: George Dangas

November 05, 2021

News Conference News TCT 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

Todd Neale

November 05, 2021

Presentation TCT 2021

MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk

Presenter: Pieter Smits

November 05, 2021

Presentation TCT 2021

Latest HBR Clinical Evidence

Presenter: Marco Valgimigli

November 04, 2021

News Conference News TCT 2021

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

Shelley Wood

November 04, 2021

News Conference News TCT 2021

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Yael L. Maxwell

November 04, 2021

News Opinion Editor's Corner TCT 2021

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

Shelley Wood

November 01, 2021

News Conference News TCT 2021

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

Yael L. Maxwell

October 22, 2021

Presentation TCT 2020

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

Presenter: Robert Byrne

October 17, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

Presentation TCT 2020

Coronary Stenting in High Bleeding Risk Patients: Is There a Preferred DES for Short DAPT?

Presenter: Davide Capodanno

October 15, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

Presentation TCT 2020

The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients

Presenter: Roxana Mehran

October 15, 2020

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Todd Neale

October 14, 2020

Presentation TCT 2020

TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study

Presenter: Robert Yeh

October 14, 2020

Advertisement

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

DAPT Duration in High Bleeding Risk Patients: Lessons From Registries

Debate: Follow the Bleeding Risk, Shorten DAPT!

Debate: Follow the Ischemic Risk, Prolong DAPT!

More DAPT Duration Data, More Calls to Tailor to Individual Patients

When to Shorten DAPT: Key Messages

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk

Latest HBR Clinical Evidence

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Coronary Stenting in High Bleeding Risk Patients: Is There a Preferred DES for Short DAPT?

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content